17:00-21:00 : WELCOME EVENING & POSTER SESSION (BIO INNOVATION)
Poster session, visit Bio Innovation, discover the regional biocluster & foodtruck
2 DAYS OF HIGH LEVEL CONFERENCES
The Innovative Therapies Days will make the connection between the academic and the industrial worlds: from research, to clinical trials, to industrialisation.
WEDNESDAY, OCTOBER 09TH
Thursday, October 10th
8:30 : REGISTRATION AND WELCOME COFFEE (KURSAAL BALLROOM)
9:00 : WELCOME ADRESS AND INTRODUCTION (KURSAAL)
Dr. Sylvain Perruche, Med Inn Pharma, Besançon, FR
Laurent Deschamps, PMT President, Besançon, FR
Representative of the President of Grand Besançon Métropole
Representative of the President of the Bourgogne Franche Comté Region
09:20-12:30 : SESSION #1 « UPCOMING INNOVATIVE THERAPIES »
Chairpersons : Dr Sylvain Perruche and Dr Susanne Behlke, Med’Inn’Pharma, Besançon, FR
09:20 : Translational potential of human platelet secretome and EVs
Pr Thierry Burnouf, Taipei Medical University’s College, Taiwan
09:50 : Evergel, an innovative extracellular vesicle-based therapy
Dr Julien Branchu, Everzom, Paris, FR
(10:20 : GOLD SPONSOR SMALL TALK)
10:25 : BREAK – EXHIBITION HALL
11:15 : Reprogramming innate immunity by early apoptotic cells (Allocetra-OTS)
Pr Dror Mevorach, Hadassah Medical Center, Jerusalem, ISR
11:45 : ASCALLO, a new alternative to treat refractory GVHD ?
Dr Anaick Moisan, Etablissement Français du Sang, Saint Ismier, FRA
12:20-14:00 : LUNCH
13:00-14:30 : Exhibition Hall – B2B MEETINGS
14:15-14:45 : SYMPOSIUM – CELL AND GENE THERAPIES: THE PATH AHEAD
Emmanuelle Cameau, Cytiva
14:45-17:30 : SESSION #2 “ CAR-T CELLS AND BEYOND ”
Chairpersons : Dr Marina Deschamps and Dr Christophe Ferrand, RIGHT Institute, Besançon, FR
14:45 : How can you register your academic CAR-T cell product in the EU
Dr Julio Delgado, Clinic Barcelona, Barcelona, SP
15:15 : From bench to bedside: Successfully translating science to therapy
MD Jens Hasskarl, Advesya, Paris, FR
(15:45 : GOLD SPONSOR SMALL TALK)
15:50 : BREAK – EXHIBITION HALL
16:30 Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR-T Cell Cancer Immunotherapy
Dr Christian Figueroa-Espada, University of Pennsylvania, Philadelphia, USA
17:00 : Epigenetic reprogramming via SUV39H1 inactivation for improved CAR T cell persistence and efficacy in primary central nervous system lymphoma
Dr Jaime Fuentealba, CellAction, Paris, FR
17:40-19:30 : B2B MEETINGS OR VISIT OF BESANÇON (on registration only)
19:30 : COCKTAIL (KURSAAL)
(on registration only)
20:00 : EVENING RECEPTION (KURSAAL)
(on registration only)
Friday, October 11th
8:30 : WELCOME COFFEE (KURSAAL)
9:00-12:00 : SESSION #3 “PATHWAYS FOR INNOVATIVE THERAPIES”
Chairpersons : Dr Jérémy Magalon, AP-HM, Marseille and Dr Olivier Humbey, IQVIA, FR
09:15 : Upcoming title
Dr Geoffrey Richard, Mabdesign, Lyon, FRA
09:45 : CAR-T: pricing, efficiency and sustainability in France
Pr Gérard de Pouvourville, ESSEC Business School, Cergy-Pontoise, FRA
10:15 : BREAK- EXHIBITION HALL
11:00 : The challenges of translating Pluripotent Stem Cell-derived therapies compared to somatic cell therapies: from starting material to product purity
Dr Jo Mountford , Scottish National Blood transfusion service , Edinburgh, Scotland
11:30 : Use of External Comparator to engage & meet market stakeholders requirements
Nora Kleinman, IQVIA, Paris, FR
12:00-14:00 : LUNCH
12:40-14:00 : Exhibition Hall – B2B MEETINGS
14:00-16:30 : SESSION #4 “CELL AND GENE THERAPIES”
Chairpersons : Pr John De Vos, INSERM U1183, CHU Montpellier and Dr Mathilde Girard, Urgo, Chenôve, FR
14:00 : Successful clinical development of a cell-based drug in canine osteoarthritis
Dr Stephane Maddens, Vetbiobank, Marcy-L’Etoile, FR
14:30 : Optimizing tumor reactivity and functions of therapeutic T cells
Dr Nathalie Labarriere, INCIT, UMR1302, Nantes, FR
15:00 -15h30 : BREAK- EXHIBITION HALL
15:30 : Alloevasion approaches to IPSC-derived cell therapies
Dr Nikolaus Trede, Century Therapeutics, Philadelphia, USA
16:00 : Advancing CD8+ Treg cell therapy to the clinic
Dr Carole Guillonneau, Center for Research in Transplantation and Translational Immunology, Nantes, FRA
16 :45-16h50 : CONCLUSION & END OF CONGRESS
Dr Christophe Ferrand, RIGHT Institute, Besançon, FR
17:00-17:45 : B2B MEETINGS
16h50 – 18:00 BEER PARTY ( on registration only)
